SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-24-000018
Filing Date
2024-03-05
Accepted
2024-03-05 07:31:51
Documents
16
Period of Report
2024-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20240305.htm   iXBRL 8-K 31061
2 EX-99.1 goss-20240305xexx991.htm EX-99.1 57203
6 GRAPHIC gossamera.jpg GRAPHIC 2160
  Complete submission text file 0001728117-24-000018.txt   224243

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20240305.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20240305_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20240305_pre.xml EX-101.PRE 12516
17 EXTRACTED XBRL INSTANCE DOCUMENT goss-20240305_htm.xml XML 3007
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 24718286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)